The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
8,499
Sort by:
Drug Testing Market Size, Share & Trends Analysis Report By Product Type (Consumables, Instruments, Rapid Testing Devices, Services), By Sample Type, By Drug Type, By End Use, By Region, And Segment Forecasts, 2021 - 2028
US$ 5,950.00
This report can be delivered to the clients within 72 Business Hours Drug Testing Market Growth & Trends The global drug testing market size is expected to reach USD 11.7 billion by 2028, according...
May 2021
120 pages
Investigation Report on China's Funeral Market 2021-2025
US$ 2,600.00
DESCRIPTION The funeral and interment industry can be divided into four parts from the perspective of service content: funeral services, disposal of remains, cemetery services, and other funeral produ...
May 2021
50 pages
Global Antibiotics Market Size study, by Action Mechanism (Cell Wall Synthesis Inhibitors, Protein Synthesis Inhibitors, DNA Synthesis Inhibitors, RNA Synthesis Inhibitors, and Mycolic Acid Inhibitors) Drug Class (Cephalosporin, Penicillin, Fluoroquinolone, Macrolide, Carbapenem, Aminoglycoside, Sulfonamide, and 7-ACA) and Regional Forecasts 2021-2027
US$ 3,218.00
Global Antibiotics Market is valued approximately USD 40.85 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 4.6 % over the forecast period 2021-2027. Antibiotics ar...
May 2021
200 pages
Breast Cancer Treatment Drug Markets in China
US$ 4,000.00
China's demand for Breast Cancer Treatment Drug has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high...
May 2021
256 pages
16S Ribosomal RNA (16S rRNA) - Drugs in Development, 2021
US$ 3,000.00
16S Ribosomal RNA (16S rRNA) - Drugs in Development, 2021 SUMMARY 16S Ribosomal RNA (16S rRNA) - Drugs in Development, 2021 provides in depth analysis on 16S Ribosomal RNA (16S rRNA) targeted pipeline...
April 2021
85 pages
23S Ribosomal RNA (23S rRNA) - Drugs in Development, 2021
US$ 3,000.00
23S Ribosomal RNA (23S rRNA) - Drugs in Development, 2021 SUMMARY 23S Ribosomal RNA (23S rRNA) - Drugs in Development, 2021 provides in depth analysis on 23S Ribosomal RNA (23S rRNA) targeted pipeline...
April 2021
70 pages
Acute Bronchitis (Respiratory) - Drugs in Development, 2021
US$ 2,000.00
Acute Bronchitis (Respiratory) - Drugs in Development, 2021 SUMMARY Acute Bronchitis (Respiratory) - Drugs in Development, 2021 provides an overview of the Acute Bronchitis pipeline landscape. The rep...
April 2021
30 pages
Adenocarcinoma (Oncology) - Drugs in Development, 2021
US$ 2,000.00
Adenocarcinoma (Oncology) - Drugs in Development, 2021 SUMMARY Adenocarcinoma (Oncology) - Drugs in Development, 2021 provides an overview of the Adenocarcinoma pipeline landscape. The report provides...
April 2021
100 pages
